NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Collections About News Help Login
Back to Results
Monophosphoryl Lipid A (MPLA) as an Innovative Immune Countermeasure to Mitigate Clinical Immunosuppression Risks for Exploration Space MissionsNo abstract available
Document ID
20190031984
Acquisition Source
Johnson Space Center
Document Type
Poster
Authors
Makedonas, George (Wyle Laboratories, Inc. Houston, TX, United States)
Varma, Tushar
Nelman-Gonzalez, Mayra (Wyle Laboratories, Inc. Houston, TX, United States)
Krieger, Stephanie (Wyle Laboratories, Inc. Houston, TX, United States)
Crucian, Brian (NASA Johnson Space Center Houston, TX, United States)
Date Acquired
October 4, 2019
Publication Date
October 1, 2018
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-E-DAA-TN61261
Report Number: JSC-E-DAA-TN61261
Funding Number(s)
CONTRACT_GRANT: NNJ15HK11B
Distribution Limits
Public
Copyright
Public Use Permitted.
Technical Review
Single Expert

Related Records

There are no records associated with this record.
No Preview Available